<?xml version="1.0" encoding="UTF-8"?>
<p id="para20">Infants and young children are typically at high risk for admission to hospital after respiratory tract infection with viruses such as respiratory syncytial virus and influenza virus.
 <xref rid="bib8" ref-type="bibr">
  <sup>8</sup>
 </xref> Immaturity of the respiratory tract and immune system is thought to contribute to severe viral respiratory disease in this age group.
 <xref rid="bib8" ref-type="bibr">
  <sup>8</sup>
 </xref> Therefore, the absence of paediatric patients with COVID-19 has perplexed clinicians, epidemiologists, and scientists. Case definitions and management strategies for children are absent because of the limited number of paediatric patients with COVID-19. In 
 <italic>The Lancet Infectious Diseases</italic>, Haiyan Qiu and colleagues
 <xref rid="bib9" ref-type="bibr">
  <sup>9</sup>
 </xref> have shed light on this under-represented population with a clinical report of 36 paediatric patients (aged 1â€“16 years) with PCR-confirmed COVID-19. Their analyses have important implications for clinical management of younger people with SARS-CoV-2 infection and social distancing policies to prevent virus transmission.
</p>
